Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery
- 1 July 2011
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 301 (1) , R15-R27
Abstract
Obesity increases the likelihood of diseases like type 2 diabetes (T2D), heart disease, and cancer, and is one of the most serious public health problems of this century. In contrast to ineffectual prevention strategies, lifestyle modifications, and pharmacological therapies, bariatric surgery is a very effective treatment for morbid obesity and also markedly improves associated comorbidities like T2D. However, weight loss and resolution of T2D after bariatric surgery is heterogeneous and specific to type of bariatric procedure performed. Conventional mechanisms like intestinal malabsorption and gastric restriction do not fully explain this, and potent changes in appetite and the enteroinsular axis, as a result of anatomical reorganization and altered hormonal, neuronal, and nutrient signaling, are the portended cause. Uniquely these signaling changes appear to override vigorous homeostatic defenses of stable body weight and compelling self-gratifying motivations to eat and to reverse defects in beta-cell function and insulin sensitivity. Here we review mechanisms of weight loss and T2D resolution after Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy bariatric surgery, two markedly different procedures with robust clinical outcomes.Keywords
This publication has 212 references indexed in Scilit:
- Decreased dopamine type 2 receptor availability after bariatric surgery: Preliminary findingsBrain Research, 2010
- Metabolic syndrome, hormones, and maintenance of T cells during agingCurrent Opinion in Immunology, 2010
- Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic DiseaseCell, 2010
- The environment within: how gut microbiota may influence metabolism and body compositionDiabetologia, 2010
- Relation of obesity to consummatory and anticipatory food rewardPhysiology & Behavior, 2009
- The Lipid Messenger OEA Links Dietary Fat Intake to SatietyCell Metabolism, 2008
- Do Incretins Play a Role in the Remission of Type 2 Diabetes after Gastric Bypass Surgery: What are the Evidence?Obesity Surgery, 2008
- Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric bandingSurgery for Obesity and Related Diseases, 2007
- Increases in morbid obesity in the USA: 2000–2005Public Health, 2007
- Prevalence of Overweight and Obesity in the United States, 1999-2004JAMA, 2006